Shenzhen Ionova Life Sciences

Shenzhen Ionova Life Sciences, based in Shenzhen, China, is a biotechnology company. Ionova Biosciences develops next-generation oncology therapeutics, aiming for new cancer treatments with clear clinical benefit and global competitiveness. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials, testing INV-8989, INV-6452 and INV-9956 in colorectal cancer, non-small-cell lung cancer, pancreatic ductal adenocarcinoma, ovarian cancer and endometrial cancer. The largest, NCT07612891 (A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumour), plans to enrol 201 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.